Paroxetine shortage — CA supply status & alternatives

Paroxetine

—

🇦🇺 AUST R 308493

In supply · Australia

Paroxetine Sandoz

In supply · 🇦🇺 Australia · short in🇨🇦 CA🇧🇪 BE

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$3.50DPMQ A$21.84details →

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Brand names
Active ingredient (INN)	Paroxetine

Therapeutic category	Auto-created by Federal Agency for Medicines and Health Products — PharmaStatus scraper

Controlled substance	No

Marketing-authorisation holders	Sandoz Pty Ltd, Generics (UK) Limited, SANDOZ LIMITED, MILPHARM LIMITED +4 more

Registrations on file	16

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$3.50

AEMP

Dispensed (DPMQ)

A$21.84

incl. fees

Pack

paroxetine 20 mg tablet, 30

Source: PBSEffective July 2026 · AUD

Other markets

🇬🇧 GB

£0.95

Drug Tariff

🇺🇸 US

US$0.06

Acquisition

🇫🇷 FR

€3.08

Retail price

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

14 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Apotex INCJubilant Biosys LTDGlaxosmithklineZydus Lifesciences LTDMedichem SASun Pharmaceutical Industries LTD+8 more

Manufacturing countries: Canada, India, United States, Spain, China · Source: FDA List of Drug Master Files

Recalls official enforcement reports

🇺🇸

PAROXETINE

Golden State Medical Supply Inc. · Nov 2023

Class IIdetails ↗

🇺🇸

PAROXETINE

Golden State Medical Supply Inc. · Nov 2023

Class IIdetails ↗

🇺🇸

PAROXETINE

Golden State Medical Supply Inc. · Nov 2023

Class IIdetails ↗

🇺🇸

PAROXETINE

Apotex Corp. · Nov 2023

Class IIdetails ↗

🇺🇸

PAROXETINE

Apotex Corp. · Nov 2023

Class IIdetails ↗

🇺🇸

PAROXETINE

Apotex Corp. · Nov 2023

Class IIdetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders16 registrations · 8 MA holders

Product	Strength	Form	Market	MA holder	Status
Noumed	20 mg	—	🇦🇺 AU	—	Active
Blooms The Chemist	20mg	—	🇦🇺 AU	Sandoz Pty Ltd	Active
PAROXETINE 30MG FILM COATED TABLETS	30MG	tablet	🇬🇧 GB	Generics (UK) Limited	Active
PAROXETINE 30MG TABLETS	30MG	tablet	🇬🇧 GB	SANDOZ LIMITED	Active
PAROXETINE 20 MG TABLETS	20 MG	tablet	🇬🇧 GB	SANDOZ LIMITED	Active
PAROXETINE 20MG FILM COATED TABLETS	20MG	tablet	🇬🇧 GB	Generics (UK) Limited	Active
PAROXETINE 20MG FILM-COATED TABLETS	20MG	tablet	🇬🇧 GB	MILPHARM LIMITED	Active
PAROXETINE 30MG FILM-COATED TABLETS	30MG	tablet	🇬🇧 GB	MILPHARM LIMITED	Active
PAROXETINE 10 MG TABLETS	10 MG	tablet	🇬🇧 GB	MORNINGSIDE HEALTHCARE LIMITED	Active
PAROXETINE 20MG TABLETS	20MG	tablet	🇬🇧 GB	MORNINGSIDE HEALTHCARE LIMITED	Active
PAROXETINE 40MG TABLETS	40MG	tablet	🇬🇧 GB	MORNINGSIDE HEALTHCARE LIMITED	Active
PAROXETINE 20 MG FILM-COATED TABLETS	20 MG	tablet	🇬🇧 GB	BRISTOL LABORATORIES LIMITED	Active
PAROXETINE 30 MG FILM-COATED TABLETS	30 MG	tablet	🇬🇧 GB	BRISTOL LABORATORIES LIMITED	Active
PAROXETINE 40 MG FILM-COATED TABLETS	40 MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
PAROXETINE 10MG FILM-COATED TABLETS	10MG	tablet	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active

+1 more registration on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.